Data for (Study ST001215)
(Analysis AN002026)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 |
|---|---|---|
| 10-HDHA | 1.2573 | 0.7105 |
| 11,12-diHETrE | 0.9149 | 1.0851 |
| 11(12)-EET | 0.9284 | 1.2149 |
| 11-beta-PGF2a/PGF2b | 1.0684 | 0.9316 |
| 11-dehydro TxB2 | 0.9607 | 1.0786 |
| 11-HDHA | 1.3122 | 0.6358 |
| 11-HEPE | 1.1217 | 0.8630 |
| 11-HETE | 1.2709 | 0.7291 |
| 12,13-diHOME | 0.9324 | 1.0676 |
| 12(13)-EpOME | 1.0602 | 0.9398 |
| 12-HEPE | 1.5501 | 0.3124 |
| 12-HETE | 1.2188 | 0.7812 |
| 12-oxoETE | 1.2825 | 0.3408 |
| 12-oxoLTB4 | 1.2300 | 0.4250 |
| 13,14-dihydro-15-keto PGA2 | 1.0253 | 0.9578 |
| 13,14-dihydro-15-keto PGD2 | 1.0600 | 0.9250 |
| 13,14-dihydro-15-keto PGE2 | 1.4092 | 0.6727 |
| 13,14-dihydro-15-keto PGF2a | 0.7255 | 1.2745 |
| 13,14-dihydro PGE1 | 1.0285 | 0.9715 |
| 13-HDHA | 1.1270 | 0.9093 |
| 13-HODE | 1.1132 | 0.8868 |
| 13-HOTrE/13-HOTrE(r) | 1.0484 | 0.9516 |
| 13-oxoODE | 1.1118 | 0.8882 |
| 14,15-diHETE | 1.1034 | 0.8819 |
| 14,15-diHETrE | 0.8555 | 1.1445 |
| 14(15)-EET | 1.1399 | 0.8729 |
| 14(15)-EpETE | 1.1408 | 0.7536 |
| 14-HDHA | 1.3872 | 0.5698 |
| 15-deoxy-delta12,14-PGD2 | 0.7961 | 1.2549 |
| 15-deoxy-delta12,14-PGJ2 | 1.0893 | 0.9196 |
| 15-HEPE | 0.9272 | 1.0624 |
| 15-HETE | 1.0286 | 0.9685 |
| 15-HETrE | 1.0471 | 0.9529 |
| 15-keto-PGE2 | 1.0000 | NA |
| 15-keto-PGF2a | 1.1461 | 0.9269 |
| 15-oxoETE | 1.0499 | 0.9501 |
| 16(17)-EpDPE | 1.0116 | 0.9870 |
| 16-HDHA | 0.8126 | 1.2498 |
| 16-HETE | 0.9140 | 1.0860 |
| 17,18-diHETE | 0.9764 | 1.0236 |
| 17(18)-EpETE | 1.2542 | 0.8729 |
| 17-HDHA | 0.7491 | 1.2788 |
| 17-HETE | 1.2805 | 0.7450 |
| 18-HEPE | 0.8489 | 1.1133 |
| 18-HETE | 1.0301 | 0.9781 |
| 19,20-diHDPA | 0.8661 | 1.1339 |
| 19(20)-EpDPE | 1.1411 | 0.8871 |
| 19/20-OH PGE2 | 1.0659 | 0.9561 |
| 19/20-OH PGF2a | 1.0924 | 0.8984 |
| 20-carboxy LTB4 | 1.0000 | NA |
| 20-HDHA | 1.2053 | 0.5895 |
| 20-HETE | 1.3005 | 0.7541 |
| 2,3-dinor-11beta-PGF2a | 1.1356 | 0.7288 |
| 2,3-dinor TxB2 | 0.9230 | 1.1540 |
| 4-HDHA | 1.2033 | 0.6272 |
| 5,15-diHETE | 1.0935 | 0.9065 |
| 5,6-diHETE | 0.5086 | 1.6879 |
| 5,6-diHETrE | 1.0185 | 0.9852 |
| 5(6)-EET | 1.0000 | NA |
| 5-HEPE | 1.0947 | 0.9148 |
| 5-HETE | 0.9455 | 1.0545 |
| 5-HETrE | 0.9116 | 1.0796 |
| 5-iPF2a-VI | 0.9313 | 1.0687 |
| 5-oxoETE | 1.0564 | 0.9507 |
| 6,15-diketo-13,14-dihydro PGF1a | 0.9068 | 1.0233 |
| 6-keto PGE1 | 0.9328 | 1.0480 |
| 6-keto-PGF1a | 0.9437 | 1.0643 |
| 7-HDHA | 1.0480 | 0.9712 |
| 8,9-diHETrE | 0.8211 | 1.1789 |
| 8(9)-EET | 0.3593 | 1.2136 |
| 8-HDHA | 1.0650 | 0.9164 |
| 8-HEPE | 0.9616 | 1.0461 |
| 8-HETE | 1.1250 | 0.8472 |
| 8-HETrE | 0.9773 | 1.0249 |
| 8-iso PGF2a | 0.8764 | 1.1544 |
| 9,10-diHOME | 0.9839 | 1.0161 |
| 9(10)-EpOME | 1.1039 | 0.8961 |
| 9-HEPE | 1.1666 | 0.8889 |
| 9-HETE | 1.1339 | 0.8513 |
| 9-HODE | 1.0539 | 0.9461 |
| 9-HOTrE | 1.1372 | 0.8628 |
| 9-oxoODE | 1.0643 | 0.9357 |
| Bicyclo PGE2 | 0.9919 | 1.0129 |
| d4-9-HODE | NA | NA |
| d4-LTB4 | NA | NA |
| d4-PGE2 | NA | NA |
| d8-5S-HETE | NA | NA |
| delta12-PGJ2 | 1.1086 | 0.9069 |
| Hepoxilin A3 | 0.3761 | 1.9983 |
| LTB4 | 1.0614 | 0.9078 |
| LTC4 | NA | 1.0000 |
| LTD4 | 1.0282 | 0.9577 |
| LTE4 | 1.0000 | NA |
| LXA4 | 0.8625 | 1.1833 |
| LXB4 | 1.2847 | 0.9288 |
| Maresin1 | NA | NA |
| PD1 | 1.5543 | 0.7228 |
| PGA1 | 0.8899 | 1.1468 |
| PGA2/PGJ2 | 1.0976 | 0.8862 |
| PGB2 | 1.1477 | 0.8523 |
| PGD2 | 1.0656 | 0.9181 |
| PGD3/PGE3 | 1.2573 | 0.5711 |
| PGE1/PGD1 | 1.0200 | 0.9700 |
| PGE2/PGD2 | 1.2066 | 0.7727 |
| PGF1a | 1.0609 | 0.9391 |
| PGF2a | 1.1367 | 0.8438 |
| PGK2 | 1.0057 | 0.9924 |
| RvD1 | 1.1609 | 0.5978 |
| RvD2 | 1.1848 | 0.8152 |
| Tetranor-12-HETE | 1.0878 | 0.9122 |
| tetranor-PGFM | 1.0871 | 0.9303 |
| TxB2 | 1.1726 | 0.8274 |
| TxB3 | 0.9657 | 1.0549 |
Factors:
| F1 | Treatment:Mirabegron |
| F2 | Treatment:Placebo |
